MLL Gene Rearranged Acute Lymphoblastic Leukemia

被引：0
|
作者：
Pieters, Rob [1 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
MLL gene; Nucleoside; Stem cell transplantation; RAS mutations; Epigenetics; STEM-CELL TRANSPLANTATION; CHILDRENS ONCOLOGY GROUP; THERAPEUTIC TARGET; FLT3; EXPRESSION; INFANT; INHIBITION; CHEMOTHERAPY; INTERFANT-99; PROFILE; ABSENCE;
D O I：
10.1016/j.clml.2018.06.053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TH-S18-ALL
引用
收藏
页码：S48 / S50
页数：3
相关论文
共 50 条
  • [41] Rearranged Infant Acute Lymphoblastic Leukemia.
    Stam, Ronald W.
    Den Boer, Monique L.
    Schneider, Pauline
    de Boer, Jasper
    Hagelstein, Jill
    Sallan, Stephen E.
    Brady, Hugh J. M.
    Armstrong, Scott
    Pieters, Rob
    BLOOD, 2008, 112 (11) : 668 - 668
  • [42] The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia
    Stumpel, Dominique J. P. M.
    Schneider, Pauline
    Pieters, Rob
    Stam, Ronald W.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (14) : 2008 - 2021
  • [43] The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia
    B V Balgobind
    C M Zwaan
    R Pieters
    M M Van den Heuvel-Eibrink
    Leukemia, 2011, 25 : 1239 - 1248
  • [44] Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
    Cruickshank, M. N.
    Ford, J.
    Cheung, L. C.
    Heng, J.
    Singh, S.
    Wells, J.
    Failes, T. W.
    Arndt, G. M.
    Smithers, N.
    Prinjha, R. K.
    Anderson, D.
    Carter, K. W.
    Gout, A. M.
    Lassmann, T.
    O'Reilly, J.
    Cole, C. H.
    Kotecha, R. S.
    Kees, U. R.
    LEUKEMIA, 2017, 31 (01) : 40 - 50
  • [45] Vorinostat and Bortezomib Combined Intensive Chemotherapy for Children with KMT2A (MLL)-rearranged Acute Lymphoblastic Leukemia
    Suzuki, Kyogo
    Muramatsu, Hideki
    Okuno, Yusuke
    Narita, Kotaro
    Kitazawa, Hironobu
    Huang, Yue
    Ichikawa, Daisuke
    Kataoka, Shinsuke
    Hamada, Motoharu
    Murakami, Norihiro
    Taniguchi, Rieko
    Kojima, Daiei
    Sekiya, Yuko
    Nishikawa, Eri
    Kawashima, Nozomu
    Narita, Atsushi
    Nishio, Nobuhiro
    Hama, Asahito
    Kojima, Seiji
    Takahashi, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S90 - S90
  • [46] Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia
    Kerstjens, Mark
    Castro, Patricia Garrido
    Pinhancos, Sandra S.
    Schneider, Pauline
    Wander, Priscilla
    Pieters, Rob
    Stam, Ronald W.
    BIOMEDICINES, 2021, 9 (07)
  • [47] Extramedullary relapse of KMT2A(MLL)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab
    Aldoss, Ibrahim
    Song, Joo Y.
    BLOOD, 2018, 131 (22) : 2507 - 2507
  • [48] Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
    M N Cruickshank
    J Ford
    L C Cheung
    J Heng
    S Singh
    J Wells
    T W Failes
    G M Arndt
    N Smithers
    R K Prinjha
    D Anderson
    K W Carter
    A M Gout
    T Lassmann
    J O'Reilly
    C H Cole
    R S Kotecha
    U R Kees
    Leukemia, 2017, 31 : 40 - 50
  • [49] Modeling the Initiation and Progression of Human MLL-Rearranged Precursor B Cell Acute Lymphoblastic Leukemia in Mice
    Chen, Zhenhua
    Yang, Lu
    Sau, Lillian
    Hu, Zunsong
    Chen, Meiling
    Zeng, Chengwu
    Shen, Chao
    Qing, Ying
    Che, Yuan
    Wu, Dong
    Tang, Tingting
    Xu, Zhaoxu
    He, Xin
    Zhang, Lianjun
    Cheng, Pu
    Weng, Hengyou
    Huang, Huilin
    Gu, Zhaohui
    Xiao, Gang
    Deng, Xiaolan
    Chen, Jianjun
    BLOOD, 2024, 144 : 2738 - 2739
  • [50] AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells
    B Accordi
    L Galla
    G Milani
    M Curtarello
    V Serafin
    V Lissandron
    G Viola
    G te Kronnie
    R De Maria
    E F Petricoin
    L A Liotta
    S Indraccolo
    G Basso
    Leukemia, 2013, 27 : 1019 - 1027
12345